Paper42865463PubMed
Cerebrospinal fluid metabolite alterations associated with human brain aging: an untargeted metabolomics study.
Pan Y and 3 others. Front Med (Lausanne), 2026.
Cite this record
ConductScience Library. Cerebrospinal fluid metabolite alterations associated with human brain aging: an untargeted metabolomics study. Papers, record 42865463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42865463
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cerebrospinal fluid metabolite alterations associated with human brain aging: an untargeted metabolomics study.
- Journal
- Front Med (Lausanne)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-14
Source PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 38033552 | Lipids and lipoproteins may play a role in the neuropathology of Alzheimer's disease. | Front Neurosci | 2023 | https://conductscience.org/library/papers/38033552 | PubMed |
| 2 | 30034877 | Ageing: Is there a role for arachidonic acid and other bioactive lipids? A review. | J Adv Res | 2018 | https://conductscience.org/library/papers/30034877 | PubMed |
| 3 | 35640460 | Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers. | Neurobiol Aging | 2022 | https://conductscience.org/library/papers/35640460 | PubMed |
| 4 | 37687175 | Gas Chromatography-Mass Spectrometry-Based Cerebrospinal Fluid Metabolomics to Reveal the Protection of Coptisine against Transient Focal Cerebral Ischemia-Reperfusion Injury via Anti-Inflammation and Antioxidant. | Molecules | 2023 | https://conductscience.org/library/papers/37687175 | PubMed |
| 5 | 36599349 | Hallmarks of aging: An expanding universe. | Cell | 2023 | https://conductscience.org/library/papers/36599349 | PubMed |
| 6 | 37179123 | Proteostatic modulation in brain aging without associated Alzheimer's disease-and age-related neuropathological changes. | Aging (Albany NY) | 2023 | https://conductscience.org/library/papers/37179123 | PubMed |
| 7 | 35794106 | Periarteriolar spaces modulate cerebrospinal fluid transport into brain and demonstrate altered morphology in aging and Alzheimer's disease. | Nat Commun | 2022 | https://conductscience.org/library/papers/35794106 | PubMed |
| 8 | 35599489 | The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-β and Tau Levels in Patients with Alzheimer's Disease. | J Alzheimers Dis | 2022 | https://conductscience.org/library/papers/35599489 | PubMed |
| 9 | 28341160 | Metabolic network failures in Alzheimer's disease: A biochemical road map. | Alzheimers Dement | 2017 | https://conductscience.org/library/papers/28341160 | PubMed |
| 10 | 32580166 | Untargeted metabolomics for uncovering biological markers of human skeletal muscle ageing. | Aging (Albany NY) | 2020 | https://conductscience.org/library/papers/32580166 | PubMed |
| 11 | 36266352 | A class of anti-inflammatory lipids decrease with aging in the central nervous system. | Nat Chem Biol | 2023 | https://conductscience.org/library/papers/36266352 | PubMed |
| 12 | 34386234 | Cerebrospinal fluid metabolomics: detection of neuroinflammation in human central nervous system disease. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/34386234 | PubMed |
| 13 | 35184896 | Brain cell type-specific cholesterol metabolism and implications for learning and memory. | Trends Neurosci | 2022 | https://conductscience.org/library/papers/35184896 | PubMed |
| 14 | 23709317 | Metabolic changes in the anterior and posterior cingulate cortices of the normal aging brain: proton magnetic resonance spectroscopy study at 3 T. | Age (Dordr) | 2014 | https://conductscience.org/library/papers/23709317 | PubMed |
| 15 | 33872003 | Ameliorative Effect of Dietary Tryptophan on Neurodegeneration and Inflammation in d-Galactose-Induced Aging Mice with the Potential Mechanism Relying on AMPK/SIRT1/PGC-1α Pathway and Gut Microbiota. | J Agric Food Chem | 2021 | https://conductscience.org/library/papers/33872003 | PubMed |
| 16 | 37110227 | Cerebrospinal Fluid Metabolomics: Pilot Study of Using Metabolomics to Assess Diet and Metabolic Interventions in Alzheimer's Disease and Mild Cognitive Impairment. | Metabolites | 2023 | https://conductscience.org/library/papers/37110227 | PubMed |
| 17 | 31993375 | Age-Related Changes in the Gut Microbiota Modify Brain Lipid Composition. | Front Cell Infect Microbiol | 2019 | https://conductscience.org/library/papers/31993375 | PubMed |
| 18 | 37845508 | Polyamine metabolite spermidine rejuvenates oocyte quality by enhancing mitophagy during female reproductive aging. | Nat Aging | 2023 | https://conductscience.org/library/papers/37845508 | PubMed |
| 19 | 37693649 | Metabolomic profiling of CSF and blood serum elucidates general and sex-specific patterns for mild cognitive impairment and Alzheimer's disease patients. | Front Aging Neurosci | 2023 | https://conductscience.org/library/papers/37693649 | PubMed |
| 20 | 18580584 | Longitudinal metabolic and cognitive changes in mild cognitive impairment patients. | Alzheimer Dis Assoc Disord | 2008 | https://conductscience.org/library/papers/18580584 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42865463
GET https://conductscience.org/api/papers/v1/42865463/references?page=2